The 2 meta-analyses also demonstrated that probiotics reduce the risk of death due to all causes , but do not have an effect on the risk of sepsis or death due to NEC .
Because of the limited data regarding synbiotics , the relationship between their use and clinical outcomes in preterm infants remains unclear .
The findings from the 2 meta-analyses of the effects of probiotic administration on the prevention of NEC show potential for such dietary supplementation .
BACKGROUND Uncertainty exists regarding the efficacy and safety of using probiotics and prebiotics in preterm infants .
AIM To review the evidence on the effects of administering probiotics and /or prebiotics to preterm infants .
Prebiotic Oligosaccharides in Dietetic Products for Infants: A Commentary by the ESPGHAN Committee on Nutrition
This article by the ESPGHAN Committee on Nutrition summarizes available information on the effects of adding prebiotic oligosaccharides to infant and follow-on formulae . Currently there are only limited studies evaluating prebiotic substances in dietetic products for infants . Although administration of prebiotic oligosaccharides has the potential to increase the total number of bifidobacteria in feces and may also soften stools , there is no published evidence of clinical benefits of adding prebiotic oligosaccharides to dietetic products for infants . Data on oligosaccharide mixtures in infant formulae do not demonstrate adverse effects , but further evaluation is recommended . Combinations and dosages in addition to those so far studied need to be fully evaluated with respect to both safety and efficacy before their use in commercial infant food products . Well- design ed and carefully conducted r and omized controlled trials with relevant inclusion /exclusion criteria , adequate sample sizes and vali date d clinical outcome measures are needed both in preterm and term infants . Future trials should define optimal quantity and types of oligosaccharides with prebiotic function , optimal dosages and duration of intake , short and long term benefits and safety . At the present time , therefore , the Committee takes the view that no general recommendation on the use of oligosaccharide supplementation in infancy as a prophylactic or therapeutic measure can be made
The 2 meta-analyses also demonstrated that probiotics reduce the risk of death due to all causes , but do not have an effect on the risk of sepsis or death due to NEC .
Because of the limited data regarding synbiotics , the relationship between their use and clinical outcomes in preterm infants remains unclear .
The findings from the 2 meta-analyses of the effects of probiotic administration on the prevention of NEC show potential for such dietary supplementation .
BACKGROUND Uncertainty exists regarding the efficacy and safety of using probiotics and prebiotics in preterm infants .
AIM To review the evidence on the effects of administering probiotics and /or prebiotics to preterm infants .